Five Danish startups enter BII’s Venture House 8 cohort with €1.3 million follow-on backing
Five Danish startups enter BII’s Venture House 8 cohort with €1.3 million follow-on backing BioInnovation Institute (BII), a Novo Nordisk Foundation Initiative, has provided an additional €1.3 million in follow-on funding to five portfolio startups – Synuca Therapeutics, Gefjon Pharma, MicroMiner, DARERL and Diasense – bringing the total support for

